Keywords: BRCA; carboplatin; debulking surgery; epithelial ovarian cancer; paclitaxel; palliative; RMI;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Breast cancer; Family history; BRCA; Health literacy; Risk assessment; Informed consent; Patient education;
Keywords: BRCA; recurrence; RRSO; staging; STIC; systematic review;
Keywords: Risk-reducing mastectomy; Contralateral prophylactic mastectomy; Multigene panel testing; BRCA; Genetic counseling;
Keywords: AP; activator protein-1; APC; adenomatous polyposis coli; ATM; ataxia-telangiectasia; BDNF-AS; brain-derived neurotrophic factor antisense; BIN1; bridging integrator 1; BMP6; bone morphogenetic protein 6; BRCA; breast cancer associated gene; CpG; cytosine
Keywords: BRCA; Genetics; Pancreatic cancer;
Keywords: Hereditary cancer syndrome; BRCA; Lynch syndrome; Screening; Risk reduction;
Keywords: BRCA; Mammogram; MRI; TP53;
Keywords: MG; Mammography; US; Ultrasound; MRI; Magnetic Resonance Imaging; BI-RADS; Breast Imaging Reporting and Data System; BC; Breast Cancer; BRCA; Breast CAncer Antigen; CC; Cranio-Caudal; MLO; Medio-Lateral-Oblique; TNBC; Triple-Negative Breast Cancer; DCIS;
Keywords: WXS; random sequencing of exonic regions selected from the genome; WGS; whole genome sequencing; TCGA; The Cancer Genome Atlas; ICGC; International Cancer Genome Consortium; TNM; TNM Classification of Malignant Tumor; GLMM; generalized linear mixed model;
Keywords: BRCA; p53; Predictor; Prognosis; Targeted therapy;
Keywords: BRCA; Early detection; Germline; Prostate; Screening;
Keywords: Breast cancer; Ovarian cancer; Genetic counseling; Genetic testing; Cost-effectiveness; BRCA;
Keywords: BRCA; breast cancer; cost-effectiveness; multigene panel testing;
Keywords: BRCA; cervical cancer; endometrial cancer; hereditary cancer; high risk; Lynch syndrome; ovarian cancer; risk reduction; screening;
Keywords: Systems Biology; Cancer Therapy; Targeted Therapy; BRCA; BRAF; Optimized Therapy; Modeling; Signaling Dynamics;
Keywords: Cancer; Flavonoids; Chemoprevention; Dietary antioxidants; DNA damage signaling and repair; Polyphenols; DNA damage detection; Genome stability; ATM; ataxia telangiectasia mutated; ATR; ATM-Rad3-related; BRCA; breast cancer proteins; CHK; checkpoint kinas
Keywords: Transvaginal laparoscopy; Fimbriae; Cytology; Screening; Ovarium cancer; BRCA;
Keywords: BRCA; Cancer; Laparoscopy; Morbidity;
Keywords: Prostate cancer; CRPC; Heterogeneity; BRCA; DRG; PARPi; PTEN;
Keywords: AML; acute myeloid leukemia; BRCA; breast cancer; BRCC3; BRCA1/BRCA2-Containing Complex Subunit 3; C; constant; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; CSC; cancer stem-like cell; EGFR; epidermal growth factor receptor; EMT; epit
Keywords: AFP; Alpha-fetoprotein; ANAs; Antinuclear antibodies; APCs; Antigen presenting cells; ANXA-1; Annexin A1; BRCA; Breast cancer susceptibility gene; CT; Cancer-testis; EGFR; Epidermal growth factor receptor; ELISA; Enzyme linked immunosorbent assay; HDR; Ho
Keywords: Breast cancer; Communication; Genetic risk; Mastectomy; Children; Young people; Genetic testing; BRCA;
Keywords: precision medicine; ovarian cancer; uterine cancer; BRCA; Lynch syndrome; risk-reduction
Keywords: Pancreatic cancer; Hereditary; Screening; Peutz-Jeghers; BRCA; Lynch syndrome; IPMN; PanIN;
Keywords: 5FU; 5-fluorouracil; A; anthracycline; BEACON; BrEAst Cancer Outcomes with NKTR-102; BRCA; breast cancer gene; CALGB; cancer and leukemia Group B; CTCs; circulating tumor cells; CI; confidence interval; CHF; congestive heart failure; DFI; disease-free int
Keywords: Risk-reducing salpingectomy; Salpingo-oophorectomy; BRCA; Lynch syndrome; Prophylactic surgery; Hereditary cancer; Endometrial cancer; Ovarian cancer
Keywords: Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
Keywords: BRCA; breast cancer; fallopian tube cancer; ovarian cancer;
Keywords: ANP; atrial natriuretic peptide; BNP; brain natriuretic peptide; Brca; breast cancer associated; BW; body weight; Col; collagenase; Con; control; CTGF; connective tissue growth factor; DAPI; 4â²,6-diamidino-2-phenylindole; Doxo; doxorubicin; Gpx1; glutat
Keywords: Cell line; High grade serous ovarian cancer; Platinum; TP53; BRCA;
Keywords: Pancreatic adenocarcinoma; Novel therapeutics; Immunotherapy; BRCA; Stromal targeting; KRAS;
Keywords: BBB; blood-brain barrier; BRCA; breast cancer associated; ER; estrogen receptor; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; DRFI; distant recurrence-free interval; DTC; disseminated tumor cell; EMT; epithelial-to-mesenchymal transition;
Keywords: ACO; Accountable Care Organizations; AEC; Atomic Energy Commission; ASCP; American Society for Clinical Pathology; ASIMO; Advanced Step in Innovative Mobility; BNP; brain natriuretic peptide; BRCA; breast cancer antigen; CAP; College of American Pathologi
Keywords: Breast cancer; Genetic testing; BRCA
Keywords: Breast cancer; BRCA; Risk reduction; Clinical decision support; Needs assessment;
Keywords: Artificial intelligence; Breast cancer; Ovarian cancer; Genetic testing; BRCA; Risk communication;
Keywords: Risk-reducing salpingo-oophorectomy; BRCA; Occult carcinoma; Serous tubal intraepithelial carcinoma;
Keywords: BRCA; ovarian cancer; ovarian dysplasia; salpingectomy; serous tubal intraepithelial carcinoma
Keywords: Breast genetic testing; BRCA; genetic risk; hereditary risk; multigene panels
Keywords: Breast cancer; Triple-negative; Chemotherapy; Adjuvant; BRCA; Precision cancer medicine;
Risk management decisions in women with BRCA1 and BRCA2 mutations
Keywords: Breast cancer; Genetic testing; BRCA; Variants of uncertain significance;
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
Keywords: BRCA; Hormone therapy; Estrogen; Progesterone; Risk-reducing salpingo-oophorectomy; Prophylactic surgery; Breast cancer; Risk;
BRCA mutations and reproduction
Keywords: BRCA; preimplantation genetic diagnosis (PGD); premature ovarian insufficiency;
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort
Keywords: Triple negative breast cancer; Neoadjuvant chemotherapy; Carboplatin; BRCA;
“I've just never gotten around to doing it”: Men's approaches to managing BRCA-related cancer risks
Keywords: BRCA; Hereditary breast and ovarian cancer; Genetics; Risk management; Patient perspectives;
Trabectedin in Ovarian Cancer: is it now a Standard of Care?
Keywords: BRCA; ovarian cancer; partial platinum sensitive relapse; trabectedin;
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study
Keywords: Biomarkers; BRCA; DNA repair; Genomics; Germline; Prostate cancer; Precision medicine;
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
Keywords: Pancreatic cancer; Veliparib; BRCA; Germline; PARP inhibitor; Platinum;